Cytosine Deaminase-TRAIL Expressing Human Adipose Stem Cells Inhibit Tumor Growth in Castration Resistant Prostate Cancer Bearing Mice with Less Toxicity
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031563 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jae Heon Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University Medical College, Seoul 04401, Republic of Korea. Hauptthemen laut MEDLINE: Cytosine Deaminase, Prostatic Neoplasms, Castration-Resistant, TNF-Related Apoptosis-Inducing Ligand, Stem Cells. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education, Science and Technology.
Abstract (Originalsprache)
Stem cells can selectively migrate toward cancer cells, and therapeutic genes can be introduced into stem cells. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in cancer cells without harming normal cells. In this study, we evaluated the inhibition of tumor growth in castration-resistant prostate cancer (CRPC) using human adipose-derived stem cells (ADSCs) engineered to express cytosine deaminase (CD) and soluble TRAIL (sTRAIL), combined with the prodrug 5-fluorocytosine (5-FC). An immortalized human ADSC line (hTERT-ADSC) was transduced with a lentiviral vector encoding CD and sTRAIL, generating ADSC.CD.sTRAIL cells. Expression of chemoattractant ligands and receptors was assessed by RT-PCR. The suicide gene effect was evaluated by 5-FC treatment, measuring cell viability and apoptosis markers in vitro. A subcutaneous CRPC mouse model was used for in vivo studies. ADSC.CD.sTRAIL cells showed enhanced migration toward prostate cancer cells. Treatment with 5-FC significantly reduced cell viability, and co-culture with PC3 cells plus 5-FC increased apoptosis marker expression. In vivo, mice treated with ADSC.CD.sTRAIL and 5-FC had significantly smaller tumor volumes than control groups, with no treatment-related toxicity observed. These findings suggest that ADSCs overexpressing CD and sTRAIL, combined with 5-FC, effectively inhibit CRPC tumor growth and represent a promising targeted therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University Medical College, Seoul 04401, Republic of Korea.
- Department of Chemistry, Kongju National University, Kongju 32588, Republic of Korea.
- Program in Biomedical Sciences, Engineering, Department of Biomedical Sciences, College of Medicine, Inha University, Incheon 22332, Republic of Korea.
ORCID-Profile: Jae Heon Kim, Hyun Young Lee, In Seok Hong
Förderung
- National Research Foundation of Korea
- Ministry of Education, Science and Technology
Zitieren
APA
Kim, J. H., Lee, H. Y., Hong, I. S., Lee, J., Lee, S. H., & Song, Y. S. (2026). Cytosine Deaminase-TRAIL Expressing Human Adipose Stem Cells Inhibit Tumor Growth in Castration Resistant Prostate Cancer Bearing Mice with Less Toxicity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031563
Vancouver
Kim JH, Lee HY, Hong IS, Lee J, Lee SH, Song YS. Cytosine Deaminase-TRAIL Expressing Human Adipose Stem Cells Inhibit Tumor Growth in Castration Resistant Prostate Cancer Bearing Mice with Less Toxicity. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031563
BibTeX
@article{Kim2026,
author = {Kim, Jae Heon and Lee, Hyun Young and Hong, In Seok and Lee, Jeongkun and Lee, Sang Hun and Song, Yun Seob},
title = {Cytosine Deaminase-TRAIL Expressing Human Adipose Stem Cells Inhibit Tumor Growth in Castration Resistant Prostate Cancer Bearing Mice with Less Toxicity},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031563}
}
EUVIMED